A novel peptide agonist of galanin receptors reduces doxorubicin-induced heart failure in rats

被引:0
|
作者
Lyubimov, R. O. [1 ]
Studneva, I. M. [1 ]
Palkeeva, M. E. [1 ]
Molokoedov, A. A. [1 ]
Prosvirnin, A. V. [1 ]
Veselova, O. M. [1 ]
Ovchinnikov, M. V. [1 ]
Eddin, O. A. Mokhi [1 ]
Sidorova, M. V. [1 ]
Pisarenko, O. I. [1 ]
机构
[1] Natl Med Res Ctr Cardiol, Moscow, Russia
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
P1863
引用
收藏
页码:473 / 473
页数:1
相关论文
共 50 条
  • [1] Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats
    Studneva, Irina
    Palkeeva, Marina
    Veselova, Oksana
    Molokoedov, Alexander
    Ovchinnikov, Michael
    Sidorova, Maria
    Pisarenko, Oleg
    CARDIOVASCULAR TOXICOLOGY, 2019, 19 (02) : 136 - 146
  • [2] Protective Effects of a Novel Agonist of Galanin Receptors Against Doxorubicin-Induced Cardiotoxicity in Rats
    Irina Studneva
    Marina Palkeeva
    Oksana Veselova
    Alexander Molokoedov
    Michael Ovchinnikov
    Maria Sidorova
    Oleg Pisarenko
    Cardiovascular Toxicology, 2019, 19 : 136 - 146
  • [3] Protective Action of a Modified Galanin Fragment in Rats with Doxorubicin-Induced Heart Failure
    I. M. Studneva
    M. E. Palkeeva
    O. M. Veselova
    A. S. Molokoedov
    R. O. Lubimov
    M. V. Ovchinnikov
    M. V. Sidorova
    O. I. Pisarenko
    Biochemistry (Moscow), Supplement Series B: Biomedical Chemistry, 2019, 13 : 167 - 172
  • [4] Protective Action of a Modified Galanin Fragment in Rats with Doxorubicin-Induced Heart Failure
    Studneva, I. M.
    Palkeeva, M. E.
    Veselova, O. M.
    Molokoedov, A. S.
    Lubimov, R. O.
    Ovchinnikov, M., V
    Sidorova, M., V
    Pisarenko, I
    BIOCHEMISTRY MOSCOW-SUPPLEMENT SERIES B-BIOMEDICAL CHEMISTRY, 2019, 13 (02) : 167 - 172
  • [5] Heart Protective Effects of Luteolin on Rats with Doxorubicin-induced Heart Failure
    Wang, Feng
    Li, Dongye
    Chen, Jing
    Hu, Wen Jin
    Liu, Yang
    LATIN AMERICAN JOURNAL OF PHARMACY, 2013, 32 (09): : 1313 - 1320
  • [6] AICAR confers prophylactic cardioprotection in doxorubicin-induced heart failure in rats
    Choksey, Anurag
    Carter, Ryan D.
    Thackray, Benjamin D.
    Ball, Vicky
    Kennedy, Brett W. C.
    Ha, Lea Hong Tuan
    Sharma, Eshita
    Broxholme, John
    Castro-Guarda, Marcos
    Murphy, Michael P.
    Heather, Lisa C.
    Tyler, Damian J.
    Timm, Kerstin N.
    JOURNAL OF MOLECULAR AND CELLULAR CARDIOLOGY, 2024, 191 : 12 - 22
  • [7] Clinical management of doxorubicin-induced heart failure
    Christiansen, S.
    JOURNAL OF CARDIOVASCULAR SURGERY, 2011, 52 (01): : 133 - 137
  • [8] Surgical Treatment of Doxorubicin-Induced Heart Failure
    Christiansen, S.
    THORACIC AND CARDIOVASCULAR SURGEON, 2010, 58 (01): : 8 - 10
  • [9] Alamandine significantly reduces doxorubicin-induced cardiotoxicity in rats
    Hekmat, Ava Soltani
    Navabi, Zahra
    Alipanah, Hiva
    Javanmardi, Kazem
    HUMAN & EXPERIMENTAL TOXICOLOGY, 2021, 40 (10) : 1781 - 1795
  • [10] The olive constituent oleuropein prevents the doxorubicin-induced heart failure in anesthetized rats
    Andreadou, I.
    Sigala, F.
    Naka, K. N.
    Ioannidis, K.
    Kavantzas, N.
    Aligiannis, N.
    Skaltsounis, A. L.
    Mikros, E.
    Iliodromitis, E. K.
    Kremastinos, D. T.
    EUROPEAN HEART JOURNAL, 2009, 30 : 425 - 426